| 000 | 00994 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250518000910.0 | ||
| 264 | 0 | _c20191206 | |
| 008 | 201912s 0 0 eng d | ||
| 022 | _a1360-0443 | ||
| 024 | 7 |
_a10.1111/add.14432 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTimko, Christine | |
| 245 | 0 | 0 |
_aCommentary on Socias et al. (2018): Clinical research perspectives on cannabis use in opioid agonist treatment. _h[electronic resource] |
| 260 |
_bAddiction (Abingdon, England) _c12 2018 |
||
| 300 |
_a2259-2260 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Comment | ||
| 650 | 0 | 4 | _aCannabis |
| 650 | 0 | 4 | _aHallucinogens |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMedical Marijuana |
| 650 | 0 | 4 | _aOpioid-Related Disorders |
| 700 | 1 | _aCucciare, Michael A | |
| 773 | 0 |
_tAddiction (Abingdon, England) _gvol. 113 _gno. 12 _gp. 2259-2260 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/add.14432 _zAvailable from publisher's website |
| 999 |
_c28870776 _d28870776 |
||